Shanghai Orsin Medical Technology Co., Ltd.

Focus on life and pursue excellence

Manufacturer from China
Verified Supplier
2 Years
Home / Products / Vacuum Blood Test Tube /

Prothrombin Time Tube with Composite Antimony System Technology and Bionic Active Membrane for Enhanced Sample Stability

Contact Now
Shanghai Orsin Medical Technology Co., Ltd.
Visit Website
City:shanghai
Province/State:shanghai
Country/Region:china
Contact Person:MsNiki Pan
Contact Now

Prothrombin Time Tube with Composite Antimony System Technology and Bionic Active Membrane for Enhanced Sample Stability

Ask Latest Price
Video Channel
Brand Name :Orsin
Model Number :Gel Clot ActivatoR
Certification :ISO 13485
Place of Origin :China
MOQ :100/pcs
Price :Negotiation
Payment Terms :L/C, D/A, D/P, T/T, Western Union
Supply Ability :20million/pcs/moth
Delivery Time :1-4 weeks
Material Types :PET/Glass
Application Scenarios :Liquid Biopsy
Sample Order :Available
Merit :Enhanced Sample Stability
Characteristic :Excellent stability
Anticoagulant System :Composite Antimony System Technology
Platelet Activity :Stability upheld
Expiration Date :Printed on the Tube
Moq Limit :18000-20000 PCS
Usage :Blood Collection and Storage
Properties :Durable and reliable
Inner Wall Treatment :Bionic active membrane
Tube Cap Type :Screw Cap
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

Product Description

  1. A specialized prothrombin time (PT) testing system comprising blood collection tubes and an INR (International Normalized Ratio) calibration foundation, engineered to deliver accurate, standardized results when used with automated analyzers.
  2. This integrated PT tube and INR normalization base is optimized for seamless compatibility with automated diagnostic equipment, ensuring consistent activation of coagulation factors and precise calculation of INR values—critical for monitoring anticoagulant therapy.
  3. Designed for clinical laboratories, the product combines a clot-activator-coated PT tube with a validated INR reference foundation, streamlining prothrombin time testing while meeting international standards for automated analyzer performance.

Core Mechanism

  1. 3.2% Sodium Citrate

    • Precise chelation of calcium ions (Ca²⁺), inhibiting coagulation cascade

    • *Critical ratio control: Anticoagulant:Blood=1:9*

    • *>10% deviation causes falsely prolonged PT/APTT*

  1. Automated Analyzer Compatibility: Pre-calibrated to integrate with 主流自动化凝血分析仪(mainstream automated coagulation analyzers), reducing manual intervention and minimizing measurement errors.
  2. INR Standardization: The built-in normalization foundation ensures results align with international INR benchmarks, enabling consistent comparisons across laboratories and testing platforms.
  3. Optimized Coagulation Activation: PT tubes feature uniform coating of clot activators, promoting rapid, stable clot formation—ideal for timely prothrombin time analysis.

Core Applications

Test Panel Clinical Significance
PT (Prothrombin Time) Warfarin monitoring/Liver function
APTT (Activated Partial Thromboplastin Time) Heparin therapy/Intrinsic pathway
Coagulation Factor Assays Hemophilia diagnosis

Critical Warnings

⚠️

  • Underfilling (90% volume): PT prolongation ≥20% (may cause false heparin resistance)

⚠️

  • *Gently invert 5-8 times immediately (vigorous shaking activates platelets)*

Automated Integration Excellence

  • Seamless hardware-software synergy with automated analyzers eliminates manual calibration steps, reducing inter-operator variability by up to 30% compared to conventional systems.
  • Proprietary interface design ensures real-time data synchronization with mainstream coagulation analyzers (e.g., Sysmex, Stago), cutting assay setup time by 40%.

2. INR Standardization Precision

  • Embedded with WHO-certified reference calibrators, the normalization foundation achieves INR result consistency within ±0.1 across different testing platforms, exceeding CLIA proficiency standards.
  • Advanced matrix-matching technology minimizes matrix effects between the PT tube’s additive and patient samples, ensuring INR values remain stable even with hemolyzed or lipemic specimens
Inquiry Cart 0